Polycomb proteins control proliferation and transformation independently of cell cycle checkpoints by regulating DNA replication

Nature Communications

Volumn 5, Issue , 2014, Pages

  Piunti, Andrea ^a   Rossi, Alessandra ^a   Cerutti, Aurora ^b   Albert, Mareike ^c   Jammula, Sriganesh ^a   Scelfo, Andrea ^a   Cedrone, Laura ^a,d   Fragola, Giulia ^a,b   Olsson, Linda ^c   Koseki, Haruhiko ^e   Testa, Giuseppe ^a   Casola, Stefano ^b   Helin, Kristian ^c   Di Fagagna, Fabrizio D'Adda ^b,f   Pasini, Diego ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^e RIKEN Center for Integrative Medical Sciences   (Japan)

^f CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; OXYGEN; POLYCOMB GROUP PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN;

CANCER; DISEASE TREATMENT; DNA; GENE EXPRESSION; INHIBITION; PROTEIN; PUBLIC HEALTH; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE CHECKPOINT; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DNA REPLICATION; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WILD TYPE; ANIMAL; CELL CULTURE; COMET ASSAY; GENETICS; IMMUNOBLOTTING; METABOLISM; NUDE MOUSE; PHYSIOLOGY;

ANIMALS; CELL CYCLE CHECKPOINTS; CELLS, CULTURED; COMET ASSAY; DNA REPLICATION; FEMALE; IMMUNOBLOTTING; MICE; MICE, NUDE; POLYCOMB-GROUP PROTEINS;

EID: 84898606069     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4649     Document Type: Article

References (64)

1. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
2. Medema, R. H. & Macurek, L. Checkpoint control and cancer. Oncogene 31, 2601-2613 (2012).
3. Hahn, W. C. et al. Creation of human tumour cells with defined genetic elements. Nature 400, 464-468 (1999). (Pubitemid 29361801)
4. Ventura, A. et al. Restoration of p53 function leads to tumour regression in vivo. Nature 445, 661-665 (2007). (Pubitemid 46232887)
5. Serrano, M. et al. Role of the INK4a locus in tumour suppression and cell mortality. Cell 85, 27-37 (1996). (Pubitemid 26116804)
6. Kamijo, T. et al. Tumour suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91, 649-659 (1997). (Pubitemid 27513656)
7. Sperka, T., Wang, J. & Rudolph, K. L. DNA damage checkpoints in stem cells, ageing and cancer. Nat. Rev. Mol. Cell Biol. 13, 579-590 (2012).
8. Kim, W. Y. & Sharpless, N. E. The regulation of INK4/ARF in cancer and aging. Cell 127, 265-275 (2006). (Pubitemid 44572384)
9. Gil, J. & Peters, G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat. Rev. Mol. Cell Biol. 7, 667-677 (2006). (Pubitemid 44268212)
10. Chen, H. et al. Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev. 23, 975-985 (2009).
11. Yang, M. H. et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat. Cell Biol. 12, 982-992 (2010).
12. Nacerddine, K. et al. Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer. J. Clin. Invest. 122, 1920-1932 (2012).
13. Jacobs, J. J. et al. Bmi-1 collaborates with c-Myc in tumourigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13, 2678-2690 (1999). (Pubitemid 29508555)
14. Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A. & van Lohuizen, M. The oncogene and Polycomb-group gene Bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164-168 (1999). (Pubitemid 29050921)
15. Bracken, A. P. et al. The Polycomb group proteins bind throughout the INK4AARF locus and are disassociated in senescent cells. Genes Dev. 21, 525-530 (2007). (Pubitemid 46409467)
16. Dhawan, S., Tschen, S. I. & Bhushan, A. Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. Genes Dev. 23, 906-911 (2009).
17. Miyazaki, M. et al. Thymocyte proliferation induced by pre-T cell receptor signaling is maintained through polycomb gene product Bmi-1-mediated Cdkn2a repression. Immunity 28, 231-245 (2008). (Pubitemid 351215231)
18. Scott, C. L. et al. Role of the chromobox protein CBX7 in lymphomagenesis. Proc. Natl Acad. Sci. USA 104, 5389-5394 (2007). (Pubitemid 47175690)
19. Dietrich, N. et al. Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus. EMBO J. 26, 1637-1648 (2007). (Pubitemid 46480949)
20. Bruggeman, S. W. et al. Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice. Genes Dev. 19, 1438-1443 (2005). (Pubitemid 41003010)
21. Gil, J., Bernard, D., Martinez, D. & Beach, D. Polycomb CBX7 has a unifying role in cellular lifespan. Nat. Cell Biol. 6, 67-72 (2004). (Pubitemid 38425732)
22. Smith, K. S. et al. Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1. Mol. Cell. 12, 393-400 (2003). (Pubitemid 37238926)
23. Mallen-St Clair, J. et al. EZH2 couples pancreatic regeneration to neoplastic progression. Genes Dev. 26, 439-444 (2012).
24. Wen, W. et al. Knockdown of RNF2 induces apoptosis by regulating MDM2 and p53 stability. Oncogene 33, 421-428 (2013).
25. Su, W. J. et al. RNF2/Ring1b negatively regulates p53 expression in selective cancer cell types to promote tumour development. Proc. Natl Acad. Sci. USA 110, 1720-1725 (2013).
26. Calao, M. et al. Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumour initiation. Oncogene 32, 3616-3626 (2012).
27. Douglas, D. et al. BMI-1 promotes ewing sarcoma tumourigenicity independent of CDKN2A repression. Cancer Res. 68, 6507-6515 (2008).
28. Datta, S. et al. Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways. Cancer Res. 67, 10286-10295 (2007). (Pubitemid 350070802)
29. Bruggeman, S. W. et al. Bmi1 controls tumour development in an Ink4a/Arfindependent manner in a mouse model for glioma. Cancer Cell 12, 328-341 (2007). (Pubitemid 47539307)
30. Piunti, A. & Pasini, D. Epigenetic factors in cancer development: polycomb group proteins. Future Oncol. 7, 57-75 (2011).
31. Serrano, M. The INK4a/ARF locus in murine tumourigenesis. Carcinogenesis 21, 865-869 (2000).
32. Qi, W. et al. Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumour cells proliferation. Proc. Natl Acad. Sci. USA 109, 21360-21365 (2012).
33. McCabe, M. T. et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 492, 108-112 (2012).
34. Knutson, S. K. et al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat. Chem. Biol. 8, 890-896 (2012).
35. Parrinello, S. et al. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat. Cell Biol. 5, 741-747 (2003). (Pubitemid 36986782)
36. Su, I. H. et al. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat. Immunol. 4, 124-131 (2003).
37. Seibler, J. et al. Rapid generation of inducible mouse mutants. Nucleic Acids Res. 31, e12 (2003).
38. Pasini, D., Bracken, A. P., Jensen, M. R., Lazzerini Denchi, E. & Helin, K. Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J. 23, 4061-4071 (2004). (Pubitemid 39472427)
39. Cao, R. & Zhang, Y. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol. Cell 15, 57-67 (2004). (Pubitemid 38850219)
40. Margueron, R. & Reinberg, D. The Polycomb complex PRC2 and its mark in life. Nature 469, 343-349 (2011).
41. de Napoles, M. et al. Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation. Dev. Cell 7, 663-676 (2004).
42. Mikkelsen, T. S. et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448, 553-560 (2007). (Pubitemid 47206934)
43. Francis, N. J., Follmer, N. E., Simon, M. D., Aghia, G. & Butler, J. D. Polycomb proteins remain bound to chromatin and DNA during DNA replication in vitro. Cell 137, 110-122 (2009).
44. Hansen, K. H. et al. A model for transmission of the H3K27me3 epigenetic mark. Nat. Cell Biol. 10, 1291-1300 (2008).
45. Duhamel, S. et al. Sef downregulation by Ras causes MEK1/2 to become aberrantly nuclear localized leading to polyploidy and neoplastic transformation. Cancer Res. 72, 626-635 (2012).
46. Li, Q. & Dang, C. V. c-Myc overexpression uncouples DNA replication from mitosis. Mol. Cell Biol. 19, 5339-5351 (1999). (Pubitemid 29339893)
47. Moldovan, G. L., Pfander, B. & Jentsch, S. PCNA, the maestro of the replication fork. Cell 129, 665-679 (2007). (Pubitemid 46802385)
48. Barrero, M. J. & Izpisua Belmonte, J. C. Polycomb complex recruitment in pluripotent stem cells. Nat. Cell Biol. 15, 348-350 (2013).
49. Leung, K. H., El Hassan, M. A. & Bremner, R. A rapid and efficient method to purify proteins at replication forks under native conditions. BioTechniques 55, 204-206 (2013).
50. Michalet, X. et al. Dynamic molecular combing: stretching the whole human genome for high-resolution studies. Science 277, 1518-1523 (1997). (Pubitemid 27449242)
51. Doksani, Y., Bermejo, R., Fiorani, S., Haber, J. E. & Foiani, M. Replicon dynamics, dormant origin firing, and terminal fork integrity after double-strand break formation. Cell 137, 247-258 (2009).
52. Bianco, J. N. et al. Analysis of DNA replication profiles in budding yeast and mammalian cells using DNA combing. Methods 57, 149-157 (2012).
53. Di Micco, R. et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638-642 (2006). (Pubitemid 44864443)
54. Lukas, C. et al. 53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress. Nat. Cell Biol. 13, 243-253 (2011).
55. Tai, Y. C., Tan, J. A. & Peh, S. C. Higher frequency of p53 gene mutations in diffuse large B-cell lymphoma with MALT component. Pathol. Int. 54, 811-818 (2004).
56. Simonitsch-Klupp, I. et al. Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome. Leukemia. 18, 146-155 (2004). (Pubitemid 38159451)
57. Davidovich, C., Zheng, L., Goodrich, K. J. & Cech, T. R. Promiscuous RNA binding by Polycomb repressive complex 2. Nat. Struct. Mol. Biol. 20, 1250-1257 (2013).
58. Herold, S., Herkert, B. & Eilers, M. Facilitating replication under stress: an oncogenic function of MYC? Nat. Rev. Cancer 9, 441-444 (2009).
59. Zheng, L. et al. Polyploid cells rewire DNA damage response networks to overcome replication stress-induced barriers for tumour progression. Nat. Commun. 3, 815 (2012).
60. Lehmann, L. et al. Polycomb repressive complex 1 (PRC1) disassembles RNA polymerase II preinitiation complexes. J. Biol. Chem. 287, 35784-35794 (2012).
61. Pasini, D., Bracken, A. P., Hansen, J. B., Capillo, M. & Helin, K. The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol. Cell Biol. 27, 3769-3779 (2007). (Pubitemid 46726184)
62. Campaner, S. et al. Cdk2 suppresses cellular senescence induced by the c-myc oncogene. Nat. Cell Biol. 12, 54-59 (2010).
63. Vella, P. et al. Tet proteins connect the O-linked N-acetylglucosamine transferase Ogt to chromatin in embryonic stem cells. Mol. Cell 49, 645-656 (2013).
64. Lebofsky, R. & Bensimon, A. Single DNA molecule analysis: applications of molecular combing. Brief Funct. Genomic. Proteomic. 1, 385-396 (2003).